Clinical Trials

NCT06451757 | RECRUITING | PHASE3
220 participants

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2026-04-14
Completion:
2028-09-30
Conditions
  • Mitochondrial Diseases
  • Maternally Inherited Diabetes and Deafness (MIDD)
  • Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
  • Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation
Interventions
  • DRUG
No Results Yet
NCT06431126 | ACTIVE_NOT_RECRUITING | NA
13 participants

Nature and Animal-assisted Activities

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2020-09-24
Completion:
2026-06-24
Conditions
  • Neuropsychiatric Syndrome
  • Autism Spectrum Disorder
Interventions
  • OTHER
No Results Yet
NCT06333899 | RECRUITING | EARLY_PHASE1
15 participants

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2025-08-03
Completion:
2029-07-01
Conditions
  • High Grade Glioma
  • Diffuse Intrinsic Pontine Glioma
  • Anaplastic Astrocytoma
  • Infant Type Hemispheric Glioma
  • Glioblastoma
  • Glioblastoma Multiforme
  • WHO Grade III Glioma
  • WHO Grade IV Glioma
  • Diffuse Midline Glioma, H3K27-altered
Interventions
  • DRUG
No Results Yet
NCT06241430 | RECRUITING | NA
60 participants

The CardioClip Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2024-12-18
Completion:
2030-06-30
Conditions
  • Heart Failure With Reduced Ejection Fraction
  • Mitral Regurgitation
Interventions
  • DEVICE
No Results Yet
NCT06191250 | TERMINATED | PHASE2
10 participants

--SuPERIOR Trial--

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2024-09-28
Completion:
2024-12-30
Conditions
  • Non-Small Cell Lung Cancer (NSCLC)
  • Clinical Staging T2b-3 N0-1 M0
Interventions
  • DRUG
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page